ABL Diagnostics, a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, has announced the expansion of its network of exclusive distributors. The distributors will offer the DeepChek® technology, a suite of Sanger & NGS assays and software systems, to laboratories performing infectious diseases genotyping. With the new expansion…
No responses yet